During this session, attendees will learn from Dr. Laura Hopkins about The Patient Decision Aid, an aid for those who are tumour tested and found to be homologous recombination proficient. The aid is created to inform and empower patients to decide whether niraparib (Zejula) is the best treatment option for them. The Patient Decision Aid will be used in the real-world Real World clinical trial of tumour testing beginning May 2023 and will eventually be made available to patients across Canada.
#Treatmentandsideeffects#Clinicaltrialsandresearch#Recurrence